Health and Chemelot Campus

For several years, governmental and knowledge organisations in the field of Life and Science have been working closely with each other, with a view to deepening the present knowledge and placing Maastricht explicitly on the international map as the centre of these knowledge fields. Parties which have pooled their expertise and networks include Maastricht University, Maastricht University Medical Centre (MUMC), Maastricht Health Campus, Chemelot Campus, Province of Limburg, The Municipality of Maastricht, MECC Maastricht and Maastricht Convention Bureau.  

Maastricht Health Campus

Since 2008, the University Hospital Maastricht (AZM) and the Faculty of Health, Medicine and Life Sciences at Maastricht University (UM) together form the eighth university medical centre in the Netherlands. Maastricht UMC + is the only UMC in the Netherlands that combines the functions of an academic institution and regional hospital. With 6,000 employees, it is also one of the largest employers in the region. Every year, the Faculty of Health, Medicine and Life Science educates more than 4,000 students. The fact that the CEO of the Maastricht Health Campus is also on the Board of the Maastricht Convention Bureau and that Congress Centre Maastricht is part of the campus, shows that intensive cooperation is of paramount importance. The Maastricht Health Campus provides many opportunities for the city as a destination for scientific meetings, focusing on the issues of mental health and brain research, cardiovascular diseases, chronic diseases and cancer, public health and primary care. The campus has unique facilities such as Tesla scanners and the Clinical Trial Centre Maastricht. The ambition of Maastricht Health Campus is to become an internationally respected specialist valorisation campus where activities are being developed based on medical and health research. On campus, there are currently 23 life science companies, such Xilloc and PathoFinder.  

Chemelot Campus

Chemelot Campus is an important location for research, development and education in the fields of chemistry and materials and related life sciences. The focus is on high-quality materials, biomedical materials and bio-based chemicals and materials. In addition, research and development of Enabling Technologies is an important focus. The ambition is to develop the Chemelot Campus into the Euro-regional base for companies and educational and research organisations in the field of chemistry and materials. Companies that already have the Campus as a home base include the chemicals group DSM, the Basic Pharma Group, the Saudi Arabian petrochemical specialist Sabic and Sekisui S-Lec, a division of Sekisui Chemical Co. Through all the developments, Maastricht has been able to bring in increasingly more international medical and chemical conferences. Examples are the European Vascular Cours, World Institute of Pain and The European Society of Regional Anaesthesia and Pain. Optional conferences relating to cooperation with the Chemelot Campus include International Mass Spectrometry and European Society of Biomaterials.